Evidence map›Paper›PMID 39572511›Full record

ArticleActa neurologica Belgica2025

Two remarkable cases of haploinsufficiency found in the DYRK1A gene.

Elifcan Taşdelen, Umut Can Tekbaş, Hasan Baş, Abdullah Sezer

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Acta neurologica Belgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elifcan TaşdelenDepartment of Medical Genetics, Ankara Etlik City Hospital, Varlık District, Halil Sezai Erkut Street, No. 5, Yenimahalle, 06170, Ankara, Türkiye. elifkarakaya2012@gmail.com.ORCID http://orcid.org/0000-0003-3917-9792
Umut Can TekbaşDepartment of Medical Genetics, Ankara Etlik City Hospital, Varlık District, Halil Sezai Erkut Street, No. 5, Yenimahalle, 06170, Ankara, Türkiye.ORCID http://orcid.org/0009-0001-6176-3103
Hasan BaşClinical Genetics Unit, Intergen Genetics and Rare Diseases Research and Application Center, Ankara, Türkiye.
Abdullah SezerDepartment of Medical Genetics, Ankara Etlik City Hospital, Varlık District, Halil Sezai Erkut Street, No. 5, Yenimahalle, 06170, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDYRK1A syndrome, also known as "Intellectual developmental disorder, autosomal dominant 7," is a syndromic intellectual disability characterized by dysmorphic features including deep-set eyes, prominent ears, and retrognathia. Patients have neurodevelopmental problems, ocular anomalies, and multisystem phenotypes. Most cases result from single nucleotide variants causing DYRK1A-haploinsufficiency, while deletions occur in < 15% of cases. This study discusses two patients with DYRK1A haploinsufficiency. CASE PRESENTATION: Patient 1 had a novel early termination codon variant in DYRK1A and Patient 2 had partial monosomy 21/monosomy 21 mosaicism, both de novo occurrences. Genetic analysis revealed that Patient 2 had DYRK1A monosomy in all cells, and dysmorphic investigations suggested facial features were more likely caused by DYRK1A-haploinsufficiency rather than by mosaic monosomy 21.

conclusionThis study is the first to describe a patient with a complex chromosomal condition leading to DYRK1A haploinsufficiency, thereby expanding the known genotype spectrum of the syndrome.

Indexed as

HaploinsufficiencyIntellectual DisabilityProtein Serine-Threonine KinasesProtein-Tyrosine KinasesDyrk KinasesHumansMosaicismDyrk KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesDYRK1AFacial dysmorphismIntellectual disabilityMonosomy 21Partial monosomy 21

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.